Class 2 Medicines Recall: Seretide Accuhaler 50 microgram/250 microgram/dose inhalation powder, pre-dispensed.

Glaxo Wellcome UK Limited is recalling one lot of Seretide Accuhaler 50/250mcg because a manufacturing issue has resulted in a small number of units not delivering the full number of doses. (EL (18) A/04)

Click here for further information on this alert.

GSK is also recalling two specific batches of Ventolin (salbutamol) 200mcg Accuhaler devices.

This action follows a manufacturing issue that may result in a small number of Accuhaler devices not delivering the full number of doses in the device.

The Accuhaler, which has a distinctive disk-like shape, is used to treat asthma, but is not widely used in the UK compared to the more commonly used Evohaler

Guidance to help patients identify if their Ventolin Accuhaler is affected by this recall and how to obtain a replacement is provided here.

No other GSK inhalers are affected by this issue, The more commonly used ‘boot’-shaped Ventolin Evohaler ‘rescue’ inhaler is not affected by this recall.

 

Recommended

Exclude medical single-use plastics from tax?

Medicine-related single-use plastic items should be exempt from a future plastic tax, argues CCA

Pharmacies urged to act on blood pressure

Community pharmacies are being invited to get involved in two blood pressure campaigns 


By using this website, you accept Pharmacy Magazine Terms of Use, Privacy Policy and Cookie Policy. Click accept to hide box. By continuing browsing you have confirmed your acceptance.